Advance Science & Medicine by Connecting Patients to Life-Saving Therapeutics
<aside>
💡
Why Double Blind Bio (DBB)?
We Accelerate the Development of Next Generation Medicines
- We work directly with Clinical Research Sites, Sponsors and Clinical Research Organizations (CROs) to embed our technology to accelerate clinical trials.
We move fast
- We went from initial idea to product in customer’s hands in three weeks. In our first six months, we onboarded 200 research sites, landed our first pharma design partner and our existing lead investors, SignalFire (Uber, Grammarly, Lime, Ro, Aura) and Define Ventures (hims & hers, Story Health) doubled down on their investment in us.
Work with Life Sciences Experts
- The founders, Shruti (CEO) and Dave (CTO), have spent their careers working at the intersection of Life Sciences/Healthcare, Data and AI on both business development and technology.
</aside>
About Us
Double Blind Bio automates administrative tasks, allowing clinical staff to focus on what matters most: patient care and advancing science. We’re building a future where clinical trials operate more autonomously by connecting sites, sponsors, and their data using AI. Our mission is to accelerate the delivery of cutting-edge therapeutics from development to market by building intelligent software that streamlines clinical trial operations.
To date, we’ve raised over $7 million in funding from our co-lead investors, SignalFire and Define Ventures, to accelerate this vision. Currently, we’re used by over 200 clinical research sites and have a handful of sponsor customers.
The Vision
We exist to accelerate scientific development and improve human well-being by increasing the efficacy of medicines worldwide.
Today, bringing a drug to market takes over 10 years and $1-2 billion, with clinical trials consuming the bulk of the time and resources, not drug discovery.
Imagine if you could cut the time and/or cost of running a clinical trial in half. According to the Jevons paradox, as costs drop, demand for running clinical trials would rise, allowing more candidate therapies and more niche treatments to be tested and to reach the market. Clinical trial operations sit at the center of this and are the problem Double Blind Bio is solving for.
What You’ll Do
- Build agentic systems that design and launch web experiences, leveraging cutting-edge AI techniques
- Architect and optimize everything from a full-stack web application, RAG (Retrievial-Augmented Generation) system, and data pipelines
- Strengthen our engineering processes, practices, culture, and technical architecture as a founding member of the engineering team
- Developing and maintaining the core application across frontend, backend, and infrastructure
- Make a meaningful impact on scientific research, medicine, and patient outcomes
Who You Are
- You are a product-first engineer
- You’re a polymath — you enjoy working on interdisciplinary fields, learning about the aspects of medicine, biology, product, and the business excites you as well as software engineering
- You’re T-shaped technically — you’re a generalist with a breath of knowledge and expertise in one area of the stack
- You have strong full-stack engineering skills and experience integrating AI